Paper of the Month - February, 2015

0 rating

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Lindsley RC, Mar BG, Mazzola E et al.
Acute myeloid leukemia (AML) can be classified, on the basis of clinical ontogeny, as secondary AML (s-AML) that occurs upon transformation of a preceding myelodysplastic syndrome (MDS) or myeloproliferative neoplasm, therapy-related AML (t-AML) that develops as a complication of leukemogenic treatments, or de novo AML that arises in the absence of demonstrable treatment exposure or preceding disease.


READER POLL

L&L poll 2
What do you consider to be the most exciting advances in therapeutics research in myeloid leukemia at present?






Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE